Skip to main navigation Skip to search Skip to main content

Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations

  • Niels Herluf Paulsen*
  • , Camilla Qvortrup
  • , Fie Juhl Vojdeman
  • , Peter Plomgaard
  • , Stig Ejdrup Andersen
  • , Anne Ramlov
  • , Birgitte Bertelsen
  • , Maria Rossing
  • , Claus Gyrup Nielsen
  • , Elke Hoffmann-Lücke
  • , Eva Greibe
  • , Hanne Spangsberg Holm
  • , Heidi Hvid Nielsen
  • , Ihab Bishara Yousef Lolas
  • , Jonna Skov Madsen
  • , Marianne Lerbaek Bergmann
  • , Morten Mørk
  • , Palle B Nielsen Fruekilde
  • , Pernille Bøttger
  • , Peter Clausager Petersen
  • Peter Henrik Nissen, Søren Feddersen, Troels K Bergmann, Per Pfeiffer, Per Damkier
*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)1400-1405
Number of pages6
JournalActa Oncologica
Volume61
Issue number11
Early online date18 Oct 2022
DOIs
Publication statusPublished - Nov 2022

Keywords

  • Denmark/epidemiology
  • Dihydrouracil Dehydrogenase (NADP)/genetics
  • Fluorouracil
  • Genotype
  • Humans
  • Neoplasms/epidemiology
  • Phenotype
  • Prevalence
  • Uracil

Cite this